Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
HOW WILL GILEAD RESPOND TO THE WUHAN UNIVERSITY APPLYING FOR A PATENT ON REMDESIVIR? READ:
https://www.inquartik.com/inq-china-coronavirus-patents-gilead-portfolio/
GO $GILD
"We are most hopeful about Gilead Sciences ’ (GILD) Remdesivir, which was developed to treat Ebola and Marburg. It is being adapted as a treatment for Covid. The in vitro data are promising; we should get more insight in four to six weeks."
https://www.barrons.com/articles/biotech-could-be-a-big-winner-in-a-post-pandemic-world-51585953254
$GILD -- READ THIS - "We are most hopeful about Gilead Sciences ’ (GILD) Remdesivir, which was developed to treat Ebola and Marburg. It is being adapted as a treatment for Covid. The in vitro data are promising; we should get more insight in four to six weeks."
https://www.barrons.com/articles/biotech-could-be-a-big-winner-in-a-post-pandemic-world-51585953254
$GILD -- READ THIS - "We are most hopeful about Gilead Sciences ’ (GILD) Remdesivir, which was developed to treat Ebola and Marburg. It is being adapted as a treatment for Covid. The in vitro data are promising; we should get more insight in four to six weeks."
https://www.barrons.com/articles/biotech-could-be-a-big-winner-in-a-post-pandemic-world-51585953254
I agree.
Well I am not, but it was a weird question from your part... so, do you not read the news?
This company is at the forefront of the COVID19 crisis. Do you not read the news...?
MASSIVE DROP ON Q1 EARNINGS REPORT 2020 EXPECTED. MSG TO KNOW MORE.
THIS IS WHERE THE ACTION SHOULD BE. NOT FCKING LGNDZ... THAT IS IRRELEVANT IN THE COVID-19 TOPIC.
Umm... okay thanks. Have you taken a recent detailed look at Goldman Sachs' portfolio? I am 99.99% sure they have ownership in the other two big contenders in the COVID-19 treatment field.
OBVIOUSLY. YOU SAID IT YOURSELF: "THIS IS WHERE THE VALUE IN LGND LIES"....
WHY IS THERE NO ACTION HERE?!?!?!
Okay, when did Goldman Sachs get in?
I do not have any more knowledge than the average guy around here. But to be so sure of something (without any medical knowledge!) that is really at the very early stages, I think seems unreasonable. Especially LGNDZ, when - and if - Remdesivir is found to be THE drug, LGND is going to be affected, and not LGNDZ.
So I'm being put into the spotlight unnecessarily? Thanks.. :) What did I say to earn this?
Partner, I own both LGND and LGNDZ. What ulterior motives are you even talking about? Sorry... laughing out loud.....
Brillant info and opinion. But this is all about LGND - why discuss this under LGNDZ? LGND is going to be huge, LGNDZ is basically a call option.
Doesn't really mean anything, I recently created this account indeed on Ihub. Does that tell you anything about my experience? Don't think so.
You are right, but LGND is still going to be big in any case - at least that's what I think right now.
You might have a point.
! IF IT HASN'T BEEN POSTED BEFORE: HERE YOU GO - https://www.sec.gov/Archives/edgar/data/886163/0000886163-20-000034-index.htm
good info, thanks for this!
Anyone can write anything on an anonymous board
ahahaha this stock should be HELD for at least mid next week! We will all see what happens by next tue-wed for sure!
101% Agreed! Let's GO!
$LGNDZ
What platform are you using to trade?
In LGNDZ? Maybe... in LGND? Definitely not.
"$300 million to buy vaccines and treatments.........."
“I know I speak for everyone at Gilead when I say how much we all wish we could help every patient in need,” company chairman and chief executive Daniel O’Day said in a statement March 28, responding to the huge demand for the drug. “Today we are working at speed to establish the temporary expanded access programs, while at the same time establishing the potential safety and efficacy of remdesivir and determining for which patients remdesivir may have activity.”
In a statement Tuesday, the company said: “Remdesivir has not demonstrated safety or efficacy to date and so there is an inherent challenge in identifying the appropriate target population for this investigational agent. From a safety perspective, we exclude patients who might be at higher risk for toxicity due to evidence of end organ damage.”
You think so? Don't think so, considering they have a drug similar to Remdesivir, currently being tested to treat Coronavirus...
Kane, they only have orders for non-medical use..... what are you saying?
oooofff.... seems almost too good. timeframe?
They simply realized what a failure they are..... time to look for other venues.
INDEED. PCTL IS A FAILURE... "OTC OF THE YEAR" MY ASS HAHAHA....
NICE FALL, ENJOYING IT GUYS? APPROVAL ON 26-MAR DID NOTHING BUT PLUMMET THE PRICE.......
Indeed, but why is LGND plummetting instead of shooting up then?
- What is the exact event that needs to happen in order for this to turn out positively for holders?
- What is the timeframe for this to happen in order for this to turn out positively for holders?
Thanks. In this case, all the people here, buying LGNDZ are hoping for this event to successfully occur within the timeframe and to cash in on the 'benefits' (as per article) and not actually on the stock price moving upwards?
Trying to find out as well.
What is the relationship between LGND and LGNDZ?